{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:21:05Z","timestamp":1777051265504,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.japh.2016.12.078","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T23:00:49Z","timestamp":1486767649000},"page":"S141-S147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S","title":["The pharmacist role in the development and implementation of a naloxone prescription program in Alabama"],"prefix":"10.1016","volume":"57","author":[{"given":"Jordan L.","family":"Wulz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. DeeAnn","family":"Dugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri M.","family":"Wensel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryn","family":"Manzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.japh.2016.12.078_bib1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/pme.12461","article-title":"Trends in U.S. emergency department visits for opioid overdose","volume":"15","author":"Hasegawa","year":"2014","journal-title":"Pain Med"},{"issue":"190","key":"10.1016\/j.japh.2016.12.078_bib2","first-page":"1","article-title":"Drug-poisoning deaths involving heroin: United States, 2000-2013","author":"Hedegaard","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"39","key":"10.1016\/j.japh.2016.12.078_bib3","first-page":"849","article-title":"Increases in heroin overdose deaths-28 states, 2013-2014","volume":"63","author":"Rudd","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2016.12.078_bib4","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.japh.2016.12.078_bib5","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.japh.2016.12.078_bib6","unstructured":"Naloxone access act, Alabama HB 208. Ala Stat 364 \u00a7 1-4 (2015)."},{"key":"10.1016\/j.japh.2016.12.078_bib7","unstructured":"Opioid OD act, Alabama HB 379. Ala Stat 307 \u00a71-4 (2016)."},{"key":"10.1016\/j.japh.2016.12.078_bib8","author":"Miller"},{"key":"10.1016\/j.japh.2016.12.078_bib11","series-title":"Annual Drug Report","first-page":"1","author":"Jefferson County Coroner","year":"2015"},{"key":"10.1016\/j.japh.2016.12.078_bib13","author":"Gordon"},{"key":"10.1016\/j.japh.2016.12.078_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","article-title":"Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability","volume":"94","author":"Strang","year":"1999","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.japh.2016.12.078_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the skid row area of Los Angeles, CA","volume":"21","author":"Wagner","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.japh.2016.12.078_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.japh.2016.12.078_bib17","first-page":"303","article-title":"Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study","volume":"82","author":"Seal","year":"2005","journal-title":"J\u00a0Urban Health"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116310275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116310275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:06:45Z","timestamp":1666742805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319116310275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1544319116310275"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2016.12.078","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacist role in the development and implementation of a naloxone prescription program in Alabama","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2016.12.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}